Literature DB >> 22065911

Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in Korea.

Hye Lim Kim1, Ju Young Do, Han Jeong Cho, Yong-Chul Jeon, Seok Joo Park, Hyeo Il Ma, Jun Ho Song, Yul Lee, Hyun Choi, Kyung Chan Choi, Yong Sun Kim, Inga Zerr, Kai Kallenberg, Yun Joong Kim.   

Abstract

Since 1987, dura mater graft-associated iatrogenic Creutzfeldt-Jakob disease (dCJD) has been reported in many countries. We report the first case of dCJD in Korea. A 54-yr-old woman, who underwent resection of the meningioma in the left frontal region and received a dura mater graft 23 yr ago presented with dysesthesia followed by psychiatric symptoms and ataxia. Her neurological symptoms rapidly progressed to such an extent that she exhibited myoclonus, dementia, and pyramidal and extrapyramidal signs within 8 weeks. The 14-3-3 protein was detected in her cerebrospinal fluid; however, an electroencephalogram did not reveal characteristic positive sharp wave complexes. Diffusion-weighted magnetic resonance images, obtained serially over 64 days, revealed the rapid progression of areas of high signal intensity in the caudate nucleus and cingulate gyrus to widespread areas of high signal intensity in the cortex and basal ganglia. Pathological examination of brain biopsy specimens confirmed the presence of spongiform changes and deposition of prion protein in the neurons and neuropils.

Entities:  

Keywords:  Creutzfeldt-Jakob Syndrome; Dura Mater Graft; Iatrogenic Disease

Mesh:

Substances:

Year:  2011        PMID: 22065911      PMCID: PMC3207058          DOI: 10.3346/jkms.2011.26.11.1515

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  14 in total

1.  Creutzfeldt-Jakob disease: management of accidental contamination of neurosurgical instruments, pathology equipment, and solutions.

Authors:  E A Bryce; K Dorovoni-Zis; D Trudeau; M Sinclair; F J Roberts
Journal:  Infect Control Hosp Epidemiol       Date:  2000-04       Impact factor: 3.254

2.  Iatrogenic Creutzfeldt-Jakob disease and its neurosurgical implications.

Authors:  D A Simpson; C L Masters; G Ohlrich; G Purdie; G Stuart; A E Tannenberg
Journal:  J Clin Neurosci       Date:  1996-04       Impact factor: 1.961

3.  Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report.

Authors:  V Thadani; P L Penar; J Partington; R Kalb; R Janssen; L B Schonberger; C S Rabkin; J W Prichard
Journal:  J Neurosurg       Date:  1988-11       Impact factor: 5.115

4.  Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1979-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-12-05       Impact factor: 17.586

5.  Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.

Authors:  R Tintner; P Brown; E T Hedley-Whyte; E B Rappaport; C P Piccardo; D C Gajdusek
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

6.  Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.

Authors:  Masahito Yamada; Moeko Noguchi-Shinohara; Tsuyoshi Hamaguchi; Ichiro Nozaki; Tetsuyuki Kitamoto; Takeshi Sato; Yosikazu Nakamura; Hidehiro Mizusawa
Journal:  Neuropathology       Date:  2009-07-29       Impact factor: 1.906

7.  Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia.

Authors:  Fiona J Brooke; Alison Boyd; Genevieve M Klug; Colin L Masters; Steven J Collins
Journal:  Med J Aust       Date:  2004-02-16       Impact factor: 7.738

8.  Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.

Authors:  M Noguchi-Shinohara; T Hamaguchi; T Kitamoto; T Sato; Y Nakamura; H Mizusawa; M Yamada
Journal:  Neurology       Date:  2007-07-24       Impact factor: 9.910

9.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

10.  [Prion disease surveillance in Japan: analysis of 1,241 patients].

Authors:  Masahito Yamada; Ichiro Nozaki; Tsuyoshi Hamaguchi; Moeko Noguchi-Shinohara; Tetsuyuki Kitamoto; Yosikazu Nakamura; Takeshi Sato; Hidehiro Mizusawa
Journal:  Rinsho Shinkeigaku       Date:  2009-11
View more
  6 in total

1.  Application of PLGA/type I collagen/chitosan artificial composite dura mater in the treatment of dural injury.

Authors:  Wanshan Bai; Xinwei Wang; Wen Yuan; Huixue Wang; Zhanchao Wang
Journal:  J Mater Sci Mater Med       Date:  2013-07-06       Impact factor: 3.896

2.  An autologous bone marrow mesenchymal stem cell-derived extracellular matrix scaffold applied with bone marrow stimulation for cartilage repair.

Authors:  Cheng Tang; Chengzhe Jin; Xiaotao Du; Chao Yan; Byoung-Hyun Min; Yan Xu; Liming Wang
Journal:  Tissue Eng Part A       Date:  2014-06-18       Impact factor: 3.845

Review 3.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

Review 4.  Vertebrate food products as a potential source of prion-like α-synuclein.

Authors:  Bryan Andrew Killinger; Viviane Labrie
Journal:  NPJ Parkinsons Dis       Date:  2017-11-24

5.  Evaluation of an Autologous Bone Mesenchymal Stem Cell-Derived Extracellular Matrix Scaffold in a Rabbit and Minipig Model of Cartilage Repair.

Authors:  Cheng Tang; Chengzhe Jin; Xiangquan Li; Jiayi Li; Xiaotao Du; Chao Yan; Shanshan Lu; Bo Wei; Yan Xu; Liming Wang
Journal:  Med Sci Monit       Date:  2019-09-30

6.  A novel equine-derived pericardium membrane for dural repair: A preliminary, short-term investigation.

Authors:  Roberto Centonze; Emiliano Agostini; Samantha Massaccesi; Stefano Toninelli; Letterio Morabito
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.